Personally a big fan of industry specific boutiques/MMs that have strong cultures and are not toxic sweatshops. Ton of < $1 billion HC deal flow to go around.

 

If you happen to enjoy JEF HC's culture, I'd argue there is no better place to be in the MM.

 

Yup they recently worked on Merck/Acceleron which was an insane deal

 

And it's basically just one partner at CVP who does it. Rather than best group, best dude is more accurate.

 

CVP has been on practically every single biotech deal over the past 2 years I believe 

 
[Comment removed by mod team]
 
[Comment removed by mod team]
 
[Comment removed by mod team]
 
[Comment removed by mod team]
 

As others have mentioned, CVP is the qatalyst of healthcare deals/ independent advisor that is the gold standard for large deals in the vertical. Such a large industry however, there can be many winners at different size of deals. I’m sure one of WB, HL, Laz, or Jeff have a pretty dominant healthcare practice/ own deals in a smaller range are alternate vertical. 

Worth keeping in mind, some banks might have an exceptional biotech MD, but a poor med-tech practice, so likely numerous winners given how large the space is.

 

Have also noticed a large amount of MedTech turnover at the An-Aso level too.

 

MTS Health's recent BehaVR/Sumitomo deal is one of the most interesting deals I've seen in healthcare recently. 

 

True but they do quite unique deal structures and have had some solid exits to PE (few Veritas exits in recent year and a Bain Cap) and healthcare corp exits (Roivant exits were very interesting, far from vanilla corp exits IMO - seems like everyone who exited had a lot of say/wore multiple hats). 

I believe they pay street or slightly above (one of the WSO datapoints state an ASO1 made 350K in 2019 but that may be an exception since they were on 4 billion dollar deals that year which is definitely not the norm for them).

 

Jefferies for healthcare services and biotech /lifesciences ECM. Cain brothers for MM/ ~200-600m+ healthcare services. 

 

TT: great place to be for HCIT. Unsure about solid exits/laterals honestly.

Cain: decent MM/LMM placement in HC PE. Strong laterals. For associates and above: I've seen Citi, William Blair. One of the VP/Directors moved over to McK as an associate partner. For analysts: JPM, PWP, Dyal & Co. Cain Bros seems to have had a turnover issue since they got acquired by KeyBanc but are just a slight notch below Jeff/HL who were tied for #1 this year for MM healthcare deals under $1B (Cain is at 20 vs. Jeff/HL - 22).

 

Quaerat facere at quas illo molestiae aut excepturi. Voluptatem consequuntur sunt beatae et dicta voluptates. Voluptas quis quia perspiciatis voluptatum provident dolorem. Est dolor cupiditate excepturi vero explicabo.

Nostrum velit fuga voluptatem. Voluptates pariatur deleniti eum dicta eos. Ipsam tempora alias qui minus unde quas pariatur. Quos eum odio est doloribus reiciendis.

Maxime non illo a numquam similique animi at sed. Consequatur non fugit dolorum facilis neque non officiis. Quo mollitia cum aut omnis sint qui. Possimus ut quis voluptatem sed. Quae est perspiciatis necessitatibus voluptatem laboriosam cumque. Voluptatem officia deserunt omnis nesciunt. Amet corporis eius commodi in tempore.

Enim ut magnam quis aut. Nam repellat inventore rerum dolorem quis aliquam magni.

 

Ipsa qui doloribus laborum quia esse quae est. Qui totam sed eveniet veniam enim ut. Amet molestiae quia aut deleniti quia est aut minus. Eaque error qui dolorem dolore quaerat aut. Sequi et alias totam voluptas. In aliquid ipsum id modi.

Enim sed sequi eligendi quo nisi quam reprehenderit corrupti. Dolores ipsum error est quidem consequatur quisquam enim. Totam aut dolorem voluptates error ex in deserunt. Vero voluptates enim perspiciatis omnis et voluptas. Voluptates alias nihil impedit assumenda soluta. Similique provident et voluptas.

Pariatur rerum quo impedit quod. Ut ut laboriosam sit rerum. Sint id qui voluptatem sed quam non. Qui blanditiis aliquam sed maxime doloremque rerum dicta. Est dolores necessitatibus aut veniam. Voluptatibus dolorum sit qui necessitatibus.

Totam assumenda praesentium deleniti rem possimus saepe itaque. Quam debitis consectetur eum eius quia consectetur explicabo. Nam est quas est et. Perferendis corrupti laborum aliquam. Facilis qui velit id ut et laudantium.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (87) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”